Upcoming Webinars

Intelligent Biomanufacturing Systems: From Design to Control in Industry 4.0

Presented by Irina Ramos, PhD, Senior Distinguished Scientist, CMC and Innovation Lead at J&J Innovative Medicine, Dr. Tiago Matos, Assistant Professor Tecnico, University of Lisbon
05th November 2026

Endotoxin Testing of Pharmaceutical Products using Synthetic Reagents

Presented by Poppy Cliffe, Senior Scientist in Microbiology, Global Product Development at AstraZeneca, Nicola Reid, Director, Portfolio Product Manager, Pyrogen & Endotoxin Detection, Charles River
06th November 2026

Enhancing Plasmid DNA Quality Through Robust Topology Measurement

Presented by Dr. Anthony Blaszczyk, Principal Scientist in the Global Biologics Department at U.S. Pharmacopeia, Mateusz Imiolek, Principal Scientist at Waters
09th November 2026

Roundtable Discussion: Interpreting the New US Pharmacopoeia Guidance for Sterility & Microbial Testing in Cell Therapy

Presented by Dr. Huiping Tu, Senior Principal Scientist, Microbiology, Global Biologics United States Pharmacopeia (USP), Dr David Roesti, Microbiology Expert/Senior Technical Steward Manufacturing Science and Technology at Novartis Pharma AG, Dr. Friedrich von Wintzingerode, Director, ADQC Microbiological Sciences at Roche-Genentech, Dr. Lori Daane, Founder and Principal Scientist at Macro Scope BioConsulting, Stephane Dubreux, Pharm.D. / MBA, Scientific Affairs Director for Pharma Quality Control at bioMérieux
11th November 2026

Sterilization and Packaging Development: The Chicken and Egg Dilemma 

Presented by Logan Luke, Senior Expert Consultant, Nelson Labs And Jean-Francois (Jeff) Zeevaert, Principal Scientist Gas Sterilization, Sterigenics
17th November 2026

Pharma Industry 4.0 Will be Advanced by the Data Enablement of People

Presented by Malcom Jeffers, Transformation Strategist, Head of Research at the International Academy of Automation Engineering, Alan Bateman, Director: Systems Architecture, Digital, and Execution at Johnson & Johnson Innovative Medicines, Dan Hill, Director, Process Analytics at Fujufilm Biotechnologies
18th November 2026

Characterization of Lipid Nanoparticles Using Macro Mass Photometry Insights into Size & Mass

Presented by Presented by Jikang Wu, Senior Principal Scientist in Analytical and Biological Mass Spectrometry at Regeneron Pharmaceuticals
19th November 2026

Aggregation Analysis in AAV: Selecting Fit-for-Purpose Assays

Presented by Margaret Butko, Ph.D., Senior Advisor of CMC Assay Development at Eli Lilly and Company, Rickard Nordström Chief Operating Officer at QuTEM
02nd December 2026

Integrating E&L Assessment and Filter Validation for Sterilizing Grade Filters used in (Bio-)Pharmaceutical Manufacturing

Presented by Presented by Lijun Song, PhD, Scientific Project Manager at Nelson Labs and Peter Cornelis, Senior expert Microbiology and Sterilization at Nelson Labs
10th December 2026

Applied Automation and Mechanistic Modeling for Purification Development of Challenging Molecules under Accelerated Timelines

Presented by Scott H. Altern, Senior Scientist II at AbbVie Bioresearch Center in Worcester, MA
11th January 2027

Navigating Assay Re-Development & Transfer to Reduce Risk & Delays in GMP Testing

Presented by Sviatlana Rose, Principal Scientist at Sanofi
15th January 2027

Strategies for Successful Implementation of New Technologies in Biomanufacturing

Presented by Irina Ramos, PhD, Senior Distinguished Scientist, CMC and Innovation Lead at J&J Innovative Medicine
19th January 2027

Controlling Cryoinjury in Cell Therapy: From Freezing, Formulation Design to Clinical Readiness

Presented by Nirnoy Dan, PhD. Senior Scientist at AstraZeneca
21st January 2027

PAT Evolution and Implementation: Navigating Regulatory Guidelines, and Best Practices for Tool Selection and Validation

Presented by Presented by Dr. Farshid Mohammadparast, Process Analytical Technology (PAT) and Chemometrics Principal Investigator at USP, Atanu Sengupta, Lead – New Technologies & External Collaborations at Dr. Reddy’s Laboratories, Parag Borgaonkar, MBA, Sr. Business Development Specialist at Thermo Fisher Scientific, Sudhir Dahal, PhD., Product Marketing Manager for Research Raman Products at Thermo Fisher Scientific
25th January 2027

Scaling Up TFF for Upstream Continuous Processing: Applications of Mechanistic Modeling

Presented by Ashna Dhingra, Bioprocess Technologies & Engineering, Senior Scientist, AstraZeneca, April Wheeler, Senior Product Manager, Microfiltration Technologies at Asahi Kasei Bioprocess
28th January 2027

Process Development to GMP Implementation of Raman Spectroscopy as a PAT Tool for the Purification of Protein Based Therapeutics

Presented by Christina Passno, Senior Staff Engineer, Preclinical Manufacturing & Process Development at Regeneron Pharmaceuticals
02nd February 2027

Accelerating Biologics Development Through Advanced Analytics and Digital Transformation

Presented by Christian Airiau, PhD, Global Head Data Sciences, CMC at Sanofi
03rd February 2027

Supporting Quality across the mRNA Product Lifecycle: From Raw Materials to CQA Assessment

Presented by Sarita Kattel, M.S, Principal Scientist, Global Biologics at US Pharmacopeia, Dr. Jamuna Vaishnav, Senior Scientist at Waters Corporation
04th February 2027

The Path to Laboratory Transformation: From Scientific Work to Scalable Capability

Presented by Leonard Blackwell, Ph.D. Senior Consultant, Lab of the Future & Robotics at Hyperplane LLC Saly Romero-Torres, Ph.D. Owner, Hyperplane LLC,
11th February 2027

Fit for Purpose Chemical Characterization Studies for Medical Devices: A Practical Approach

Presented by Sandi Schaible, President and Founder of Bonded in Science, LLC
24th February 2027

A Systematic Approach to Responding to Microbial Contamination Events in Biopharmaceutical Manufacturing

Presented by Hilary Chan, Global Sterility Assurance and Microbiology Lead at Takeda, Doug Botkin, PhD, Scientific Portfolio Specialist at Charles River Laboratories
03rd March 2027

Transforming Biomanufacturing: Why Architecture Must Precede Analytics

Presented by Martin Kockx, Principal Business Analyst & Architect in AI Systems, CMC Technology at Vertex Pharmaceuticals
16th March 2027

Confirming Gene Modifications on Release Using Flow Cytometry Assays

Presented by Akshata Ijantkar, Sr Principal Scientist at Bristol Myers Squibb.
13th April 2027

Roundtable Discussion: Bridging Across Analytical Methods for Therapeutic Proteins and Novel Modalities

Presented by Dr. Anthony Blaszczyk, Principal Scientist in the Global Biologics Department at U.S. Pharmacopeia
26th April 2027